Detalhe da pesquisa
1.
The accuracy and intra- and interobserver variability of PSMA PET/CT for the local staging of primary prostate cancer.
Eur J Nucl Med Mol Imaging
; 51(6): 1741-1752, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38273003
2.
Evolution of European prostate cancer screening protocols and summary of ongoing trials.
BJU Int
; 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38469728
3.
Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy.
BJU Int
; 133 Suppl 4: 14-22, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37858931
4.
99m TcPSMA-radioguided surgery in oligorecurrent prostate cancer: the randomised TRACE-II trial.
BJU Int
; 2024 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38346924
5.
Membranous urethral length measurement on preoperative MRI to predict incontinence after radical prostatectomy: a literature review towards a proposal for measurement standardization.
Eur Radiol
; 34(4): 2621-2640, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37737870
6.
First-in-patient study of OTL78 for intraoperative fluorescence imaging of prostate-specific membrane antigen-positive prostate cancer: a single-arm, phase 2a, feasibility trial.
Lancet Oncol
; 24(5): 457-467, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37062295
7.
Is radiotherapy after radical prostatectomy associated with higher other-cause mortality?
Cancer Causes Control
; 34(12): 1139-1144, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37522983
8.
A hybrid radioactive and fluorescence approach is more than the sum of its parts; outcome of a phase II randomized sentinel node trial in prostate cancer patients.
Eur J Nucl Med Mol Imaging
; 50(9): 2861-2871, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37036490
9.
Delphi consensus project on prostate-specific membrane antigen (PSMA)-targeted surgery-outcomes from an international multidisciplinary panel.
Eur J Nucl Med Mol Imaging
; 2023 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38012448
10.
Tolerability of concurrent external beam radiotherapy and [177Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial).
BMC Cancer
; 23(1): 268, 2023 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36959540
11.
The prognostic value of lymph node staging with prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and extended pelvic lymph node dissection in node-positive patients with prostate cancer.
BJU Int
; 131(3): 330-338, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36069585
12.
Using prostate-specific membrane antigen positron-emission tomography to guide prostate biopsies and stage men at high-risk of prostate cancer.
BJU Int
; 132(6): 705-712, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37620288
13.
External validation of the Rotterdam prostate cancer risk calculator within a high-risk Dutch clinical cohort.
World J Urol
; 41(1): 13-18, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36245015
14.
A standardized method to measure the membranous urethral length (MUL) on MRI of the prostate with high inter- and intra-observer agreement.
Eur Radiol
; 33(5): 3295-3302, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36512044
15.
3D-Reconstructed Contact Surface Area and Tumour Volume on Magnetic Resonance Imaging Improve the Prediction of Extraprostatic Extension of Prostate Cancer.
J Digit Imaging
; 36(2): 486-496, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36547859
16.
Final Analysis of the Magnetic Resonance Imaging in Active Surveillance Trial.
J Urol
; 208(5): 1028-1036, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35947521
17.
Predicting early outcomes in patients with intermediate- and high-risk prostate cancer using prostate-specific membrane antigen positron emission tomography and magnetic resonance imaging.
BJU Int
; 129(1): 54-62, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34028165
18.
Standardised uptake values as determined on prostate-specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer.
BJU Int
; 129(6): 768-776, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35166426
19.
The Predictive Value of Preoperative Negative Prostate Specific Membrane Antigen Positron Emission Tomography Imaging for Lymph Node Metastatic Prostate Cancer.
J Urol
; 205(6): 1655-1662, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33530746
20.
Intraoperative Strategies to Reduce Catheter-Related Bladder Discomfort in the Early Postoperative Period after Robot-Assisted Radical Prostatectomy.
J Urol
; 205(6): 1671-1680, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33605794